Shopping Cart (0)
My Account

Shopping Cart
SELECTBIO Conferences Circulating Tumour Cells Europe

Katharina Pachmann's Biography



Katharina Pachmann, Professor, University of Jena

Degrees and Diplomas
1973 Staatsexamen Humanmedizin in München
1974 German Dissertation
1977 Swedish Dissertation
1993 Habilitation in experimenteller Hämatologie

Professional and research experience
1974-1975 Educational grant DFG: Stockholm, Institutet för Cellforskning; and Max Planck Institute for Biochemistry, Martinsried
1976-1977 Research grant DFG: Institute for Hematology GSF, München
1977-1982 Postdoc: Institute for Hematology der GSF, München
1984-1989 Postdoc: I. Medical Clinic, Klinikum rechts der Isar, München
1989-1996 Postdoc: Medical Clinic, Klinikum Innenstadt der Ludwig-Maximilians Universität, München
1996-1998 Visiting Scientist: MD Anderson Cancer Center Houston Texas Section of Molecular Hematology and Therapy
1999 Visiting Scientist: LKH Universitätsklinikum Graz Gemeinsame Einrichtung für Klinische Immunologie, Jean-Dausset Laboratorium
2000-2012 Experimental Hematology und Oncology Clinic for Internal Medicine II Friedrich Schiller-Universität Jena
Since 2012 Senior Researcher, Transfusion Center Bayreuth, Germany

Katharina Pachmann Image

A Nondissipative Approach for Detection and Isolation of Circulating Epithelial Tumor Cells Allows for Timely Therapy Monitoring (Enumeration), Molecular Characterization (Expression Profiling) and Determination of Genetic Heterogeneity (Gene Analysis of Single Tumor Cells) During the Course of Disease.

Thursday, 10 May 2012 at 16:00

Add to Calendar ▼2012-05-10 16:00:002012-05-10 17:00:00Europe/LondonA Nondissipative Approach for Detection and Isolation of Circulating Epithelial Tumor Cells Allows for Timely Therapy Monitoring (Enumeration), Molecular Characterization (Expression Profiling) and Determination of Genetic Heterogeneity (Gene Analysis of Single Tumor Cells) During the Course of Disease.SELECTBIOenquiries@selectbiosciences.com

Monitoring CETC provides the earliest and most reliable indicator of successful treatment. It also, for the first time, allows molecular characterisation of individual circulating tumor cells and help to reveal mechanisms involved in relapse. 


Add to Calendar ▼2012-05-10 00:00:002012-05-11 00:00:00Europe/LondonCirculating Tumour Cells EuropeSELECTBIOenquiries@selectbiosciences.com